| 1 |
LU1540961759 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD |
+1,74 % |
+18,68 % |
-0,02 |
| 2 |
LU1897414642 |
Janus Henderson Horizon Biotechnology Fund E2 USD |
+1,03 % |
+27,63 % |
-0,04 |
| 3 |
LU2026682919 |
Candriam Equities L Biotechnology, V2 - Capitalisation |
+1,32 % |
+20,65 % |
-0,04 |
| 4 |
LU1540962054 |
HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD |
+1,22 % |
+19,52 % |
-0,05 |
| 5 |
LU0942225912 |
Candriam Equities L Biotechnology, R - Capitalisation |
+1,09 % |
+20,63 % |
-0,05 |
|
|
| 27 |
LU0400035332 |
UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse Q-acc, USD |
-2,65 % |
+22,16 % |
-0,22 |
|
|
| 78 |
LU0767968745 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating |
-9,92 % |
+12,12 % |
-1,00 |
| 79 |
DE000A3DCA95 |
BIT Biotech Opportunities S |
-31,22 % |
+30,97 % |
-1,08 |
| 80 |
LU0415392835 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating |
-13,00 % |
+14,05 % |
-1,08 |
| 81 |
DE000A3DCBA0 |
BIT Biotech Opportunities I-II |
-31,41 % |
+30,94 % |
-1,09 |
| 82 |
LU0415392595 |
Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating |
-13,61 % |
+14,05 % |
-1,12 |